NTES [NetEase] 6-K: (Original Filing)

[Contact for Media and Investors: Cassia Curran NetEase, Inc. cassia@corp.netease.com Tel: (+86) 571-8985-2076 Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1) 212-481-2050 NetEase Reports First Quarter 2015 Unaudited Financial Results (Beijing — May 13, 2015) — NetEase, Inc. (NASDAQ: NTES), one of China’s leading Internet and online game services providers, today announced its unaudited financial results for the first quarter ended] [FORM 6-K NETEASE, INC. 26/F, SP Tower D Form 20-F x Form 40-F o o o NETEASE, INC. Form 6-K TABLE OF CONTENTS Page]

By | 2016-03-26T14:13:35+00:00 May 14th, 2015|Categories: Chinese Stocks, NTES, SEC Original|Tags: , , , , , |0 Comments

NTES [NetEase] 6-K: Contact for Media and Investors: Cassia Curran NetEase,

[Contact for Media and Investors: Cassia Curran NetEase, Inc. cassia@corp.netease.com Tel: (+86) 571-8985-2076 Brandi Piacente Investor Relations brandi@corp.netease.com Tel: (+1) 212-481-2050 NetEase Reports First Quarter 2015 Unaudited Financial Results (Beijing — May 13, 2015) — NetEase, Inc. (NASDAQ: NTES), one of China’s leading Internet and online game services providers, today announced its unaudited financial results for the first quarter ended] [FORM 6-K NETEASE, INC. 26/F, SP Tower D Form 20-F x Form 40-F o o o NETEASE, INC. Form 6-K TABLE OF CONTENTS Page]

By | 2016-03-26T14:15:00+00:00 May 14th, 2015|Categories: Chinese Stocks, NTES, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Announces Resignation of an Independent Director HONG KONG, China, May 14, 2015 — China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that Mr. Julian J. Wolhardt, one of the Company’s independent directors, has resigned] [FORM 6-K Commission Filing Number: 001-34541 CHINA CORD BLOOD CORPORATION 48th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Description 99.1]

By | 2016-03-27T08:52:31+00:00 May 14th, 2015|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Receives Site Inspection Notification for EV71 Vaccine Production Facilities BEIJING, May 14, 2014 -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the Company received site inspection notification for the commercial production facilities of its EV71 vaccine candidate from the China Food and Drug Administration (CFDA). This notification represents a significant step] []

By | 2016-03-16T06:30:07+00:00 May 14th, 2015|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: China Cord Blood Corporation Announces Resignation of an

[China Cord Blood Corporation Announces Resignation of an Independent Director HONG KONG, China, May 14, 2015 — China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that Mr. Julian J. Wolhardt, one of the Company’s independent directors, has resigned] [FORM 6-K Commission Filing Number: 001-34541 CHINA CORD BLOOD CORPORATION 48th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Description 99.1]

By | 2016-03-27T08:53:44+00:00 May 14th, 2015|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Receives Site Inspection Notification for EV71 Vaccine

[Sinovac Receives Site Inspection Notification for EV71 Vaccine Production Facilities BEIJING, May 14, 2014 -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the Company received site inspection notification for the commercial production facilities of its EV71 vaccine candidate from the China Food and Drug Administration (CFDA). This notification represents a significant step] []

By | 2016-03-16T06:31:13+00:00 May 14th, 2015|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

KZ [KONGZHONG] F-6 POS: (Original Filing)

[POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 FOR AMERICAN DEPOSITARY SHARES EVIDENCED BY AMERICAN DEPOSITARY RECEIPTS ______________ KONGZHONG CORPORATION (Exact name of issuer of deposited securities as specified in its charter) ______________ N/A ______________ Cayman Islands ) (Jurisdiction of incorporation or organization of issuer ______________________________________ CITIBANK, N.A. ) (Exact name of depositary] [KongZhong Corporation AND CITIBANK, N.A., As Depositary, AND ALL HOLDERS AND BENEFICIAL OWNERS OF AMERICAN DEPOSITARY SHARES OUTSTANDING UNDER THE TERMS OF THE DEPOSIT AGREEMENT, DATED AS OF JULY 14, 2004 Amendment No. 1 to Deposit Agreement Dated as of__________, 2015 Table of Contents Page ARTICLE I DEFINITIONS 2 SECTION 1.01 Definitions 2 SECTION 1.02 Effective Date 2 ARTICLE II] [DEPOSIT AGREEMENT by and among KONGZHONG CORPORATION AND CITIBANK, N.A., as Depositary, AND THE HOLDERS AND BENEFICIAL OWNERS OF AMERICAN DEPOSITARY SHARES HEREUNDER Dated as of July 14, 2004 TABLE OF CONTENTS ARTICLE I DEFINITIONS 2 Section 1.1 "Affiliate" 3 Section 1.2 "ADS Record Date" 3 Section 1.3 "American Depositary Receipt(s)", "ADR(s)" and "Receipt(s)" 3 Section 1.4 "American Depositary Share(s)"] [KongZhong Corporation As of May 11, 2010 Citibank, N.A. - ADR Department 388 Greenwich Street New York, New York 10013 Restricted ADSs /Affiliate (Cusip # 50047P997) Ladies and Gentlemen: Deposit Agreement Company Citibank Depositary ADSs Affiliate Holders The Company desires to establish procedures to enable Affiliates of the Company, the names of which will be provided by the Company to]

CTC [IFM Investments] 6-K: (Original Filing)

[Century 21 China Real Estate Reports First Quarter 2015 Unaudited Financial Results BEIJING, China, May 14, 2015 - IFM Investments Limited (OTCQB: CTCLY) (“Century 21 China Real Estate” or the “Company”), a leading comprehensive real estate services provider and the exclusive franchisor for the CENTURY 21 ® brand in China, today announced its unaudited financial results for the first quarter] [FORM 6-K IFM INVESTMENTS LIMITED 26/A, East Wing, Hanwei Plaza No.7 Guanghua Road, Chaoyang District Beijing, 100004 People’s Republic of China Form 20-F x Form 40-F o o o o No x IFM INVESTMENTS LIMITED]

Skip to toolbar